The broad objective of this proposal is to continue development of hairpin ribozyme as an agent for the efficient specific cleavage of heterologous RNA sequences. By developing and engineering this ribozyme to efficiently cleave specific sequences in the human immunodeficiency virus type 1 (HIV-1), it has potential application as an AIDS therapeutic. The first specific aim of this proposal is to develop optimal hairpin ribozymes for specific sites in the HIV-1 sequence. Initially, the ribozymes to be developed are designed to cleave specific sites in the gag, tat and pol transcripts of HIV-1. Both the conventional hairpin ribozyme and a newly engineered hairpin tetraloop ribozyme will be used.
The second aim i s to test these ribozymes in vivo (mammalian cell culture) for their ability to cleave HIV-1 sequences. Both phenotypic and molecular (RNA) analyses will be done in both systems to determine in vivo effectiveness.
The third aim i s to test in vivo activity of a newly developed and catalytically improved hairpin tetraloop ribozyme designed to cleave a target sequence in the HGPRT system. The HGPRT system is an excellent model and will be used for the initial determination of in vivo activity of this hairpin tetraloop ribozyme. Both phenotypic (resistance to 8-azaquanine) and molecular (RNA) effects will be determined. Results to date suggest that the hairpin ribozyme may be an important addition to the therapeutic modalities available for the treatment of AIDS. Hairpin based ribozymes may be particularly advantageous since the conditions required for their optimum function are near physiological, and they are capable of very high catalytic efficiencies. In addition to HIV-1, this approach should also be applicable to eliminate a wide variety of deleterious RNAs whether cellular or viral. The significance of which is far reaching.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI029870-06
Application #
2065271
Study Section
AIDS and Related Research Study Section 4 (ARRD)
Project Start
1990-04-01
Project End
1996-03-31
Budget Start
1995-04-01
Budget End
1996-03-31
Support Year
6
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Northern Illinois University
Department
Biology
Type
Schools of Arts and Sciences
DUNS #
City
De Kalb
State
IL
Country
United States
Zip Code
60115
Lian, Y; De Young, M B; Siwkowski, A et al. (1999) The sCYMV1 hairpin ribozyme: targeting rules and cleavage of heterologous RNA. Gene Ther 6:1114-9
Shippy, R; Siwkowski, A; Hampel, A (1998) Mutational analysis of loops 1 and 5 of the hairpin ribozyme. Biochemistry 37:564-70
Siwkowski, A; Humphrey, M; De-Young, M B et al. (1998) Screening for important base identities in the hairpin ribozyme by in vitro selection for cleavage. Biotechniques 24:278-84
DeYoung, M B; Siwkowski, A; Hampel, A (1997) Determination of catalytic parameters for hairpin ribozymes. Methods Mol Biol 74:209-20
Hampel, A; DeYoung, M B; Galasinski, S et al. (1997) Design of the hairpin ribozyme for targeting specific RNA sequences. Methods Mol Biol 74:171-7
Siwkowski, A; Shippy, R; Hampel, A (1997) Analysis of hairpin ribozyme base mutations in loops 2 and 4 and their effects on cis-cleavage in vitro. Biochemistry 36:3930-40
Siwkowski, A (1997) T7 transcript length determination using enzymatic RNA sequencing. Methods Mol Biol 74:91-7
Vinayak, R; Andrus, A; Sinha, N D et al. (1995) Assay of ribozyme-substrate cleavage by anion-exchange high-performance liquid chromatography. Anal Biochem 232:204-9
Yu, M; Poeschla, E; Yamada, O et al. (1995) In vitro and in vivo characterization of a second functional hairpin ribozyme against HIV-1. Virology 206:381-6
Altschuler, M; Tritz, R; Hampel, A (1992) A method for generating transcripts with defined 5' and 3' termini by autolytic processing. Gene 122:85-90